Last Updated: 11/10/14
Last price: 26.42 Total volume: 92,215
RAVN Stock Chart - 1 Month
RAVN Stock Chart - 3 Month
RAVN Stock Chart - 6 Month
RAVN Stock Chart - 1 Year
RAVN Stock Chart - 2 Year
Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...
Continue Reading
Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...
Continue Reading
The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...
Continue Reading
The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...
Continue Reading
ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...
Continue Reading
Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....
Continue Reading
Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...
Continue Reading
Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...
Continue Reading
Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...
Continue Reading
Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...
Continue Reading
Overview of the Clinical Trials Market The global clinical trials market is expected to reach a significant value of USD 102.12 billion by 2031. This represents a strong compound annual growth rate (CAGR) of 8.7% from 2024 to 2031. The growth is largely due to urbanization and a growing middle class, which have resulted in more sedentary lifestyles. This lifestyle change...
Continue Reading
High Tide Inc. Reports Strong Quarterly Results High Tide Inc., a leading cannabis retail brand, has announced remarkable first-quarter results, achieving record revenues of $142.5 million. This milestone represents an 11% growth compared to the same period last year, reflecting the company's strong market position and effective business strategies. Remarkable Growth in...
Continue Reading
Disney's Leadership Transition: A New Era Begins Walt Disney Co has made a commendable decision in appointing James P. Gorman, the Executive Chairman of Morgan Stanley, as the new Chairman of the Board. This transition is set to occur on January 2, 2025, as he takes over from Mark G. Parker, who has dedicated nine years to the role. Understanding the Upcoming CEO Search...
Continue Reading
SK Telecom Becomes Founding Member of MIT GenAI Impact Consortium SK Telecom (NYSE: SKM) recently joined the MIT GenAI Impact Consortium, marking a significant step in its exploration of generative AI technologies. This partnership aims to delve into the commercialization of AI advancements, involving close collaboration with MIT faculty and several global industry...
Continue Reading
SaverOne Signs Major Agreement for Fleet Safety Implementation 200 SaverOne systems to be installed for enhanced safety SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a pioneering technology firm dedicated to improving transportation safety, has embarked on a significant collaboration with a prominent multinational company in the construction sector. This agreement comes...
Continue Reading